Galmed Pharmaceuticals (GLMD) Tax Provisions (2013 - 2018)

Galmed Pharmaceuticals (GLMD) posted quarterly Tax Provisions of $75000.0 for Q3 2018, down 28.57% quarter-over-quarter from $105000.0 in Q3 2016.

Galmed Pharmaceuticals (GLMD) Tax Provisions (2013 - 2018) Analysis & Trends

Galmed Pharmaceuticals' Tax Provisions history runs 4 years deep, the most recent figure standing at $75000.0 for Q3 2018.

In Q3 2018, Tax Provisions changed N/A year-over-year to $75000.0; the TTM figure through Dec 2018 stood at $75000.0 (changed N/A YoY), while the FY2024 annual figure was $22000.0, down 98.62% from the prior year.
Tax Provisions for Q3 2018 stood at $75000.0, down from $105000.0 in the prior quarter.
The five-year high for Tax Provisions was $105000.0 in Q3 2016, with the low at $1000.0 in Q2 2016.
The 3-year median for Tax Provisions is $52000.0 (2014), against an average of $52500.0.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Galmed Pharmaceuticals	2.31 Mn	-9.57 Mn	-	-

Download Data